Forget Britvic! I’d rather buy this overlooked growth stock

Zaven Boyrazian analyses a growth stock perfectly positioned to take advantage of the rising trend in seeking to live healthier lifestyles.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

There’s a growing trend of people becoming more alert to the ingredients they’re consuming. Branded fast-food providers are offering healthier vegan options, and the global consumption of sugar-sweetened beverages is being hit as sugar taxes are introduced to tackle obesity. Companies within the beverages industry in particular — such as Britvic and The Coca-Cola Company — are having to adapt to healthier methods of achieving their signature — like the ones being offered by this growth stock — in order to retain their customers.

The opportunity

Treatt (LSE:TET) is a chemicals company that specialises in the design and manufacture of natural flavours and fragrance solutions for over 900 clients.

The firm offers a diverse portfolio of products that are widely applied throughout the food & beverage industry as well as cleaning supplies industry.

What’s more, by using all-natural ingredients in its solutions, clients don’t have a long list of chemicals printed all over their products that would deter customers. This competitive advantage has made Treatt very sticky with its clients.

growth stock
Image: Treatt

The growth stock works directly with its clients and suppliers in the development of new flavours and fragrances as well as ensuring that quality isn’t compromised.

As such, the R&D department has seen a continually rising budget, attracting a wide array of talented laboratory researchers who make the design and development of the bespoke solutions possible.

The financials

Despite some initial disruptions from the Covid-19 pandemic, the firm has continued to perform in line with expectations and ahead of 2019 results, with its Health & Wellness products leading the charge with a 16% increase in revenue.

  Citrus Health & Wellness Tea & Coffee Fruits & Vegetables Herbs, Spices & Florals Aroma & HICs
Revenue (£m) 54.5 7.6 6.5 7.6 12 21
1-Year Growth (%) -10 16 -2 10 8 0
Revenue Portion (%) 50 7 6 7 11 19

While Citrus – the most prominent portion of revenue – saw a 10% decline in sales, the overall underlying profit from this segment increased compared with 2019.

In addition the firm experienced rising demand for citrus co-products for industrial and household cleaning products across the globe. Therefore I think that the decline is likely linked to minor disruptions to operations in the early stages of the pandemic.

All other segments bar Tea & Coffee – which saw a 45% increase in revenue in the first half of 2020 – have seen growth in line with expectations.

The risk factor

The firm’s reliance on natural ingredients for its products has given it a valuable competitive advantage over rivals. But it has also exposed it to fluctuating crop commodity prices – especially the price of orange oil.

A sudden price increase in these commodities would have an adverse impact on the level of profitability of the business. However the growth stock has strong pricing power with its clients. It would likely be able to pass costs on to them for a short period of time. Of course, the opposite could occur. The price of orange oil has declined from $13/kg to nearly $4/kg since 2017, leading to an increase in profit margins.

Along with global food & beverage trends shifting towards a healthier lifestyle, the desire for exotic flavours and fragrances has grown. I believe Treatt’s design and manufacturing infrastructure around the world places it in the perfect position to continue creating a series of bespoke products for its ever-expanding roster of clients.

Zaven Boyrazian does not own shares in Treatt. The Motley Fool UK has recommended Treatt. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Female student sitting at the steps and using laptop
Investing Articles

UK stocks: the contrarian choice for 2026

UK stocks aren’t the consensus choice for investors at the moment. But some smart money managers who are looking to…

Read more »

Investing Articles

Down 20% in 2025, shares in this under-the-radar UK defence tech firm could be set for a strong 2026

Cohort shares are down 20% this year, but NATO spending increases could offer UK investors a huge potential opportunity going…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

New to investing? Here’s Warren Buffett’s strategy for starting from scratch

Warren Buffett says he could find opportunities to earn a 50% annual return in the stock market if he was…

Read more »

Investing Articles

Can the sensational Barclays share price do it all over again in 2026?

Harvey Jones is blown away by what the Barclays share price has been doing lately. Now he looks at whether…

Read more »

Investing Articles

Prediction: in 2026 mega-cheap Diageo shares could turn £10,000 into…

Diageo shares have been burning wealth lately but Harvey Jones says long-suffering investors in the FTSE 100 stock may get…

Read more »

Investing Articles

This overlooked FTSE 100 share massively outperformed Tesla over 5 years!

Tesla has been a great long-term investment, but this lesser-known FTSE 100 company would have been an even better one.

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

I’m backing these 3 value stocks to the hilt – will they rocket in 2026?

Harvey Jones has bought these three FTSE 100 value stocks on three occasions lately, averaging down every time they fall.…

Read more »

Investing Articles

Can the barnstorming Tesco share price do it all over again in 2026?

Harvey Jones is blown away by just how well the Tesco share price has done lately, and asks whether the…

Read more »